How PEG 3350 Works for Constipation and Bowel Prep

PEG 3350 is an osmotic laxative that works by pulling water into the colon, softening stool and making it easier to pass. Sold under brand names like MiraLAX and GlycoLax, it has become one of the most widely used over-the-counter treatments for constipation in both adults and children. Its popularity rests on a combination of strong clinical evidence, a safety profile that looks similar to placebo in trials, and a mechanism that is straightforward enough to dose-adjust at home.

How It Works

PEG 3350 is a large, water-soluble polymer molecule. When you dissolve it in a glass of water or juice and drink it, the molecule travels through your stomach and small intestine without being broken down or absorbed to any meaningful degree. Once it reaches the colon, it holds onto water through osmosis, preventing the colon from reabsorbing that water back into the body as it normally would. The result is stool with a higher water content, which is softer and bulkier. That increased bulk stimulates the colon’s natural contractions, which move things along.

This water-holding effect is dose-dependent: more PEG means more water retained in the colon, which is why the same compound can serve as a gentle daily laxative at low doses and a full bowel-cleanout agent at high doses before a colonoscopy.

What Happens to It in Your Body

Almost none of the PEG 3350 you swallow enters your bloodstream. Pharmacokinetic studies have confirmed that orally administered PEG 3350 is minimally absorbed, rapidly excreted, and primarily eliminated through the stool, not the kidneys or liver.¹ When researchers measured how much PEG 3350 actually showed up in urine after a bowel-preparation dose, the amount ranged from roughly 0.01% to 0.5% of the total ingested amount.² In practical terms, you drink the stuff, it does its job in the colon, and you excrete virtually all of it. This near-total non-absorption is the main reason PEG 3350 has such a mild side-effect profile: a drug that never enters circulation has very few systemic effects to cause.

Efficacy in Adults

The standard adult dose is 17 grams of powder once daily, dissolved in about 240 mL of liquid. At that dose, multiple controlled trials have established that PEG 3350 reliably improves stool frequency and consistency.³ A post-hoc analysis of a randomized trial using strict FDA-defined endpoints found that about 42% of patients on PEG 3350 met the response threshold, compared with 13% on placebo. The same analysis showed meaningful reductions in hard stools per week and in cramping scores.⁴

The effects are not limited to chronic constipation. A short-term trial in people with occasional constipation found that PEG 3350 significantly reduced straining and stool hardness within a single week, and participants preferred it over their previous laxative.⁵ For people dealing with constipation over months or years, an open-label study tracked patients for up to two years and found that roughly 80–90% were treated successfully at each follow-up, with the response holding steady over time rather than fading.⁶ That durability matters, because a laxative that loses effectiveness after a few weeks is not much help for a chronic condition.

How It Compares to Other Laxatives

Lactulose, a synthetic sugar that also works osmotically, is probably the most commonly compared alternative. In children, head-to-head randomized trials have consistently favored PEG 3350. One trial found that PEG 3350 was more effective and caused fewer side effects than lactulose in infants and children.⁷ Another showed that children on PEG 3350 had faster colonic transit times than those on lactulose.⁸ A third trial applying strict Rome IV diagnostic criteria reported that the PEG 3350 group had higher weekly stool frequency and a significant drop in painful bowel movements within the first week, while the lactulose group actually saw an increase in painful movements initially.⁹

A systematic review and network meta-analysis pooling 19 studies confirmed that both PEG and lactulose beat placebo, but PEG increased weekly bowel movements by about 1.8 more per week than lactulose as well as compared to placebo.¹⁰ In adults, a controlled-environment trial comparing PEG 3350 plus electrolytes to prucalopride (a prescription drug that works by stimulating serotonin receptors in the gut) found PEG 3350 to be at least as effective, with statistically significant advantages on most secondary measures including stool weight, consistency, and straining.¹¹

A review grading evidence quality rated PEG and lactulose as supported by “grade A” evidence for constipation, while magnesium hydroxide (the active ingredient in Milk of Magnesia) did not have enough data for a comparable rating.¹² Stimulant laxatives like senna and bisacodyl work through a different mechanism entirely, triggering direct contractions of the colon wall, and are generally recommended for short-term use. PEG 3350’s osmotic approach avoids that kind of direct stimulation, which is one reason clinicians are more comfortable with long-term dosing.

Use in Children

PEG 3350 has become a first-line treatment for childhood constipation, a remarkably common problem that can lead to stool withholding, fecal impaction, and significant distress for both kids and parents. Evidence supports its safety and efficacy in pediatric populations, though data in children younger than two is limited.¹³

For fecal impaction specifically, a dose-response study found that three days of PEG 3350 cleared the impaction in about 75% of children overall, with higher doses (1 to 1.5 g per kg of body weight per day) working in 95% of cases compared to 55% at lower doses. Side effects at those higher doses included bloating in about 18% of children and diarrhea in 13%, but no clinically significant electrolyte changes were observed.¹⁴ A study of 89 children using PEG 3350 combined with sodium picosulphate for disimpaction found significant reductions in stool visible on X-rays, with complete resolution of fecal masses in about 45% after a first round of treatment and the remainder needing a second high-dose cycle.¹⁵

Pediatric dosing is typically weight-based for impaction (the studies above used 1 to 1.5 g/kg/day) and lower for maintenance therapy, often starting at around 0.4 to 0.8 g/kg/day and adjusting based on response. The flexibility of the powder form makes dose-tuning straightforward for parents: you can add a little more or a little less until the stool consistency is right.

Safety and Side Effects

The safety record of PEG 3350 is unusually clean for a drug that has been used for decades. Across multiple clinical trials in both adults and children, including elderly populations, the side-effect profile has been comparable to placebo.¹⁶ The most common complaints are the predictable ones for a stool-softening agent: bloating, gas, cramping, and occasional diarrhea, especially at higher doses or at the start of therapy. In one pediatric trial, PEG did not cause clinically significant side effects at all.¹⁷

The main safety concern that gets discussed, particularly among parents of children on PEG 3350, is whether the compound might cause neuropsychiatric symptoms. This concern gained visibility through online parent groups and media coverage. Regulatory agencies including the FDA have looked into this. To date, no controlled clinical studies have established a causal link between PEG 3350 and neuropsychiatric effects. The FDA did commission studies to examine whether small amounts of ethylene glycol and diethylene glycol (toxic compounds chemically distinct from polyethylene glycol) might be present as trace impurities. The amounts detected were far below levels considered harmful, and the molecular structure of PEG 3350 itself is fundamentally different from those smaller, toxic glycols. Still, the concern persists in some communities, and it is worth knowing the distinction: polyethylene glycol is a large polymer chain, while ethylene glycol (antifreeze) is a small molecule with completely different properties and toxicity.

With Electrolytes or Without

PEG 3350 is sold in two main formulations. One is plain powder (MiraLAX, various generics). The other contains added electrolytes, typically sodium chloride, sodium bicarbonate, and potassium chloride (GoLYTELY, MoviPrep, and similar products used for bowel prep). The electrolytes are added to replace salts that might be lost when large volumes of fluid pass through the colon quickly, which matters more at the high doses used for colonoscopy preparation than at the daily 17-gram laxative dose.

For constipation treatment, a network meta-analysis across 19 studies found no difference in efficacy between PEG with electrolytes and PEG without: both increased weekly bowel movements by about 1.8 to 1.9 more than placebo, and there were no differences in safety or tolerability between the two.¹⁸ A pediatric trial comparing PEG 3350 plus electrolytes to PEG 4000 (a slightly different molecular weight, used more commonly in Europe) for fecal disimpaction also found no significant difference in success rates, with about 84–86% of children achieving disimpaction in both arms. The PEG 4000 group did report better palatability, which can matter quite a bit when you are trying to get a reluctant five-year-old to drink the stuff.¹⁹

The practical upshot: for everyday constipation treatment, the electrolyte-free version is easier to take (it is nearly tasteless when mixed into liquid) and equally effective. The electrolyte versions exist mainly for higher-volume bowel preparations where fluid and salt losses are larger.

Bowel Preparation for Colonoscopy

Before PEG-based bowel preps became standard, colonoscopy preparation involved some genuinely unpleasant options. PEG solutions transformed the experience, though drinking several liters of salty liquid is still nobody’s favorite activity. The standard approach uses PEG 3350 with electrolytes in large volumes (typically 2 to 4 liters), consumed the day before or split between the evening before and the morning of the procedure.

A case series of 245 patients found that a low-volume powder PEG 3350 formula used as the sole bowel prep achieved effective colon cleansing and may serve as an alternative to the traditional high-volume approach.²⁰ In children, a one-day PEG 3350 bowel prep regimen was effective in 93% of cases, and neither the child’s age nor a history of constipation significantly altered the success rate.²¹ These findings have made PEG-based preps the standard in both adult and pediatric gastroenterology.

Effects on the Gut Microbiome

This is where the science gets genuinely interesting and a bit unsettling. Because PEG 3350 works by flooding the colon with water, it creates an environment of osmotic stress that bacteria have to deal with. At the high doses used for bowel preparation, the effect on gut bacteria is substantial. A study in human volunteers found that bowel lavage with PEG dropped the total microbial load by about 31-fold. While bacterial levels and community composition were largely restored within two weeks, about a fifth of participants lost the individual-specific signature of their microbiome, and recovery speed depended on how the prep was taken.²²

Animal research has gone further. A study using mice colonized with human gut bacteria found that even a relatively mild PEG treatment (designed to be gentler than a colonoscopy prep) shifted the microbial community within 24 hours. Most bacterial groups returned to a stable state within a week after PEG stopped, but that new stable state was significantly different from the pre-treatment baseline. More than 75% of final bacterial abundance represented groups that had been permanently altered, while control mice that never received PEG showed only about 5% variation over the same period.²³ A mouse study specifically examining PEG 3350 confirmed that it changed microbiome diversity, though it did not detect behavioral changes in the animals.²⁴

What does this mean for people taking a daily 17-gram dose? The honest answer is that we do not know with certainty. The bowel-prep studies involve much larger volumes that essentially rinse out the colon entirely, which is a very different situation from a daily maintenance dose. No studies have tracked the long-term microbiome effects of standard laxative-dose PEG 3350 in humans. It is plausible that small daily doses cause only minor perturbations, but the animal data serves as a reminder that any osmotic agent powerful enough to change stool consistency is powerful enough to alter the bacterial ecosystem it passes through.

Constipation-Predominant Irritable Bowel Syndrome

People with irritable bowel syndrome that leans toward constipation (IBS-C) often reach for PEG 3350, and their doctors sometimes recommend it. A randomized, double-blind trial in patients with hypersensitive constipation-predominant IBS found that PEG improved stool consistency and showed a trend toward reducing blood in stool, but it did not significantly alter rectal sensitivity or overall IBS symptom scores.²⁵ This is an important distinction. PEG 3350 treats the constipation component of IBS-C effectively, but IBS involves visceral hypersensitivity and disordered gut-brain signaling that a simple osmotic laxative does not address. If your main complaint is infrequent, hard stools, PEG 3350 will help. If your main complaint is abdominal pain and bloating that happen to come with constipation, you may need something that targets the underlying IBS as well.

Use in Elderly Patients

Constipation becomes more common with age, driven by reduced physical activity, medications (especially opioids, calcium-channel blockers, and iron supplements), and changes in gut motility. PEG 3350 is particularly well-suited for older adults for the same reason it works well generally: minimal absorption means minimal drug interactions and almost no systemic effects. The pharmacokinetic profile is the same in older and younger adults.²⁶ In the long-term open-label study mentioned earlier, elderly patients actually had slightly higher success rates than the overall group, with 84–94% meeting treatment goals depending on the month assessed.²⁷

Veterinary Use

PEG 3350 is not just a human medication. It has found a niche in veterinary medicine, particularly for cats with chronic constipation or megacolon. A safety study found that all cats consumed PEG 3350 in their food for four weeks without changes in weight or food intake, and all achieved soft stools. Effective doses varied widely between individual cats, so individualized dosing is necessary. The study did note mild, non-clinical hyperkalemia (slightly elevated blood potassium), though the cause was unclear.²⁸ Veterinarians also use PEG 3350 for dogs and horses, generally following the same logic as human use: it is inert enough that species-specific metabolic differences matter very little.

Quality Control and Trace Impurities

One lesser-known aspect of PEG 3350 manufacturing involves ensuring the purity of the final product. Ethylene oxide, the small molecule used as a starting material in PEG synthesis, is a known carcinogen, and regulatory standards require that only trace amounts remain in the finished product. Analytical research has identified that a PEG degradation product called methyl formate can co-elute with ethylene oxide in standard testing methods, potentially causing false readings. Newer analytical methods can separate the two, confirming that what looks like ethylene oxide in some tests is actually the comparatively harmless degradation product.²⁹ This is a niche concern for most consumers, but it explains some of the periodic alarm about “antifreeze chemicals in MiraLAX” that circulates online. The manufacturing reality is that PEG 3350 is a well-characterized, heavily tested pharmaceutical product, and the trace impurity levels are tightly regulated.